Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Drug Trial News

RSS
Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

Abacavir linked to increased cardiovascular risk in HIV patients, study finds

Abacavir linked to increased cardiovascular risk in HIV patients, study finds

PrEPVacc HIV vaccine trial shows no reduction in infections

PrEPVacc HIV vaccine trial shows no reduction in infections

Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

People of color and white women underrepresented in clinical trials due to systematic biases

People of color and white women underrepresented in clinical trials due to systematic biases

NIH launches Phase 1 trial for innovative nasal COVID-19 vaccine

NIH launches Phase 1 trial for innovative nasal COVID-19 vaccine

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

Gene therapy milestone at SickKids offers hope for children with SPG50 neurodegenerative disorder

Gene therapy milestone at SickKids offers hope for children with SPG50 neurodegenerative disorder

Clinical trial seeks to evaluate safety of new EV-D68 treatment

Clinical trial seeks to evaluate safety of new EV-D68 treatment

Assessing clinical benefit and safety in trial waivers for treatment-refractory cancers

Assessing clinical benefit and safety in trial waivers for treatment-refractory cancers

Lenacapavir: A breakthrough in long-acting HIV prevention for cisgender women

Lenacapavir: A breakthrough in long-acting HIV prevention for cisgender women

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Extended-release ketamine tablets offer new hope for treatment-resistant depression

Extended-release ketamine tablets offer new hope for treatment-resistant depression

New curative treatment for sickle cell disease shows promising results in international trial

New curative treatment for sickle cell disease shows promising results in international trial

New ketamine slow-release tablet shows promise in treating severe depression

New ketamine slow-release tablet shows promise in treating severe depression

Ketamine tablets offer new hope for treatment-resistant depression

Ketamine tablets offer new hope for treatment-resistant depression

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.